CD44 and breast cancer: We discovered that the mRNA levels of various genes were upregulated in CD44 knockdown cells, and we focused on FOXA2, which has been reported to inhibit epithelial to mesenchymal transition in breast cancer [24,25,45] (Figure 2a; Figure S2a).